Schedule 13D ownership disclosure

ANIKA THERAPEUTICS INC

Security class unavailable · CUSIP: 035255108

Event date: 2024-05-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-003936
Form type
SC 13D/A
Filer
Anika Therapeutics, Inc.
CIK
CIK 898437
Filed
May 30, 2024
Reporting period
May 28, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub